AFT confirms listing plans
Initial public offer and dual listing on the cards for drug maker.
Auckland-based drug maker AFT Pharmaceuticals has confirmed plans for an initial public share offer and listing on the NZX and ASX.
In a statement, founder and chief executive Dr Hartley Atkinson said the time was right to consider an IPO and raise capital for growth.
“We believe our business is
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Tim Hunter
Fri, 09 Oct 2015
Fri, 09 Oct 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
AFT confirms listing plans
52309